Literature DB >> 20534999

Computerized N-acetylcysteine physician order entry by template protocol for acetaminophen toxicity.

Trevonne M Thompson1, Jenny J Lu, Louisa Blackwood, Jerrold B Leikin.   

Abstract

Some medication dosing protocols are logistically complex for traditional physician ordering. The use of computerized physician order entry (CPOE) with templates, or order sets, may be useful to reduce medication administration errors. This study evaluated the rate of medication administration errors using CPOE order sets for N-acetylcysteine (NAC) use in treating acetaminophen poisoning. An 18-month retrospective review of computerized inpatient pharmacy records for NAC use was performed. All patients who received NAC for the treatment of acetaminophen poisoning were included. Each record was analyzed to determine the form of NAC given and whether an administration error occurred. In the 82 cases of acetaminophen poisoning in which NAC was given, no medication administration errors were identified. Oral NAC was given in 31 (38%) cases; intravenous NAC was given in 51 (62%) cases. In this retrospective analysis of N-acetylcysteine administration using computerized physician order entry and order sets, no medication administration errors occurred. CPOE is an effective tool in safely executing complicated protocols in an inpatient setting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20534999     DOI: 10.1097/MJT.0b013e3181e3b0de

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  2 in total

1.  Cost analysis before and after implementation of a computerized physician order entry order form for enoxaparin.

Authors:  Rebecca S Pettit; Christopher R Zimmerman; Cesar Alaniz; Michael P Dorsch
Journal:  P T       Date:  2012-02

2.  Lessons learned from the reimbursement profile of a mature private medical toxicology practice: office-based practice pays.

Authors:  Trevonne M Thompson; Jerrold B Leikin
Journal:  J Med Toxicol       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.